About HumanCode
HumanCode is a company based in Denver (United States) founded in 1994 was acquired by Publicis Sapient in August 2000. HumanCode has raised $5 million across 1 funding round from investors including Publicis Sapient and Austin Ventures. HumanCode operates in a competitive market with competitors including 23andMe, Helix, Rejuvenate Bio, DDC Paternity Tests and Novogene Corporation, among others.
- Headquarter Denver, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 1 rounds
-
Latest Funding Round
$5 M (USD), Series A
Mar 15, 1999
-
Investors
Publicis Sapient
& 1 more
-
Employee Count
Not available
-
Acquired by
Publicis Sapient
(Aug 09, 2000)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of HumanCode
HumanCode has successfully raised a total of $5M through 1 strategic funding round. The most recent funding activity was a Series A round of $5 million completed in March 1999. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HumanCode
HumanCode has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Publicis Sapient and Austin Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in Texas-based companies.
|
Locked | Locked | Locked | |
|
Digital business transformation services are provided to diverse industries.
|
Locked | Locked | Locked |
Investor details for HumanCode
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HumanCode
Investment portfolio details for HumanCode
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HumanCode
Detailed financials for HumanCode
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Humancode Comparisons
Peer comparison for HumanCode
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HumanCode
HumanCode operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 23andMe, Helix, Rejuvenate Bio, DDC Paternity Tests and Novogene Corporation, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
DNA tests and personalized diagnostics are provided for various specialties.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
Detailed competitors of HumanCode
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Humancode
Complete news archive for HumanCode
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HumanCode
HumanCode was founded in 1994 and raised its 1st funding round 5 years after it was founded.
HumanCode is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
HumanCode is a funded company, having raised a total of $5M across 1 funding round to date.
HumanCode was founded in 1994 in Denver, United States, as a startup focused on health technology. Apps and digital experiences are created to provide consumers with genetic-based insights for managing health and wellness. Integration of human-centered design, mobile platforms, machine learning, and genetic research is employed to deliver personalized recommendations. Operations remain in stealth mode within the genomics sector.
HumanCode's top competitors include 23andMe, Helix and Novogene Corporation.
HumanCode has 2 investors. Key investors include Publicis Sapient, and Austin Ventures.